Deception at the Cannes Lions Festival
Misleading campaigns highlight this year’s big ad event.
Vytorin Cholesterol Pill
Merck has agreed to settle two class-action lawsuits filed in 2008 against it and Schering-Plough Corp. (which Merck has since acquired) over its cholesterol medication Vytorin. The settlement is for a whopping $688 million. The two lawsuits were filed by shareholders of the companies and alleged, among other things, that the companies made false and misleading statements regarding the effectiveness and economic success of the drug in press releases and other public disclosures.
The Latest
True Tone’s ‘Tan-Through’ Swimwear
Consumers may want to see through many of this company’s claims.
Court Cancels ‘Click-to-Cancel’ Rule
It won’t get any easier to cancel those annoying subscriptions.
US Cellular: ‘Four Free Phones and Four Lines for $90’
What you need to know about this offer.
Monetizing Minors: Aneliese German (aka Lisi Shops)
What’s this kidfluencer doing promoting a “youth cream”?